This work is licensed under a Creative Commons Attribution 4.0 International License.
Sequence 10 from Patent US 20120302729
General Information
DRACP ID DRACP01412
Peptide Name Sequence 10 from Patent US 20120302729
Sequence EVILVGGMT
Sequence Length 9
UniProt ID Q5R511 O35501 Q3ZCH0 P38647 P48721 P38646 Q5ZM98 P22774 Q8I0H7 Q05931 A0L4Z2 Q2VYT1 A8ZRW3 B6IVA4 C6E643 B5EC42 B3E7W9 B8FGS3 Q2RNE6 C6BSF2 A9HEA3 Q39PT7 B8J402 Q2LUH6 Q74H59
PubChem CID Not available
Origin Synthetic construct
Type Synthetic peptide
Classification
Active ACP
Activity Information
Hemolytic Activity Not available
Normal (non-cancerous) Cytotoxicity Not available
Target Not available
Affinity Not available
Mechanism Not available
Nature Anticancer
Structure Information
Helicity Not available
Linear/Cyclic Not available
Disulfide/Other Bond Not available
N-terminal Modification Not available
C-terminal Modification Not available
Other Modification None
Chiral L
Physicochemical Information
Formula C40H71N9O13S
Absent amino acids ACDFHKNPQRSWY
Common amino acids GV
Mass 106100
Pl 3.85
Basic residues 0
Acidic residues 1
Hydrophobic residues 4
Net charge -1
Boman Index 1277
Hydrophobicity 151.11
Aliphatic Index 151.11
Half Life
Mammalian: 1 hour
Yeast: 30 min
E.coli: >10 hour
Extinction Coefficient cystines 0
Absorbance 280nm 0
Polar residues 3
Amino acid distribution
Literature Information
Literature 1
Pubmed ID Not available
Title Not available
Doi Not available
Year Not available
Patent
Patent ID US 2012/0302729 A1
Patent Title Anticancer anti-mortalin peptide antibody.
Other Iinformation Granted Patent Family: 8s / 8ex; Family Jurisdictions: EP, US, WO, JP; Legal Status: Inactive; Application No: 201013514755; Filed:Dec 9, 2010; Published: Nov 29, 2012; Earliest Priority: Dec 10, 2009; Granted: Nov 19, 2013
Other Published ID EP2511371A1 EP2511371A4
This work is licensed under a Creative Commons Attribution 4.0 International License.